Perspectives and Profiles in Research Informatics and Systems Biology: A Sourcebook

   Single User - $495
   Hard Copy Mail Delivery - $495
   Corporate License - $990
   Online Download plus 1 Hard Copy - $745

Published Sep 1, 2002 | 149 Pages | Pub ID: KLI451436

The informatics landscape is a difficult one to map. Competing suppliers, technologies, and architectures make the field confusing enough, but how informatics will ultimately shape the process of drug discovery—and indeed, the clinical practice of medicine—is an even larger question. Call it research informatics, systems biology, or bio-IT, the siliconization of the life sciences is a movement not yet fully understood.

That’s why Kalorama is taking a step back and letting leading figures in the informatics landscape ruminate on how things are shaping up. In this new sourcebook on informatics, nine thought leaders from industry, academia, and the government provide their insights, in their own words, on everything from the emerging role of the laboratorian to the necessity computing power to the new frontier of personalized medicine.

We’ve combined these individual perspectives with profiles of the top 25 companies competing in the informatics space. Each profile provides contact information, recent revenue information, core technology, key alliances, current products, pipeline products, and a strategic summary of the company’s position and outlook.

Although somewhat different from our usual comprehensive market research study, we believe that this sourcebook will enable forward-looking executives get a handle on how informatics is progressing as an industry and how it will impact the future of medicine.

Part I: Perspectives

    The Right Stuff
    • Gary Skuse, Director of Bioinformatics, Rochester Institute of Technology

    The Emergence of Biology and Medicine as Information-Based Sciences

    • George Poste, CEO of Health Technology Networks, former CSO, SmithKline Beecham

    Big Blue: The Great Facilitator

    • Jeffrey Augen, Director of Business Development, IBM Life Sciences

    Preparing for a More Personalized Approach to Medicine

    • Kathryn C. Zoon, PhD, Center for Biologics Evaluation and Research, U.S. Food & Drug Administration

    The Power of Systems Biology

    • Leroy Hood, MD, President, Director, and Founding Member, Institute for Systems Biology

    The Future of Medicine

    • Michael Bevilacqua, MD, PhD, CEO, Source Precision Medicine

    Integrating Functional Proteomics

    • Michael Becker, Interim CEO, AxCell Biosciences

    Merck’s Longtime Commitment to Bioinformatics

    • Richard A. Blevins, Director of Informatics Worldwide, Merck & Co.

    Back to the Future

    • Stephen Lincoln, Executive VP, Product Development, and CSO, InforMax

Part II: Profiles

  • ACLARA Biosciences, Inc.
  • Affymetrix, Inc.
  • Applied Biosystems Group
  • Caliper Technologies Corporation
  • Celera Genomics Group
  • Cellomics
  • Ciphergen Biosystems, Inc.
  • Gene Logic, Inc.
  • Human Genome Sciences, Inc.
  • Incyte Genomics
  • InforMax, Inc.
  • Integrated Genomics7
  • Lexicon Genetics Incorporated
  • LION bioscience AG
  • Millennium Pharmaceuticals, Inc.
  • Orchid BioSciences, Inc.
  • Packard BioScience
  • Phase-1 Molecular Toxicology, Inc.
  • Spotfire, Inc.
  • Sun Microsystems Life Sciences Group
  • Tripos, Inc.
  • Vertex Pharmaceuticals, Inc.

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.